Bank Of America Corp Trevena Inc Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $1,423 - $889,500	-8,895 Reduced 14.72%	51,552 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.5 $9,652 - $24,131	-48,262 Reduced 44.4%	60,447 $24,000
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $130,846 - $201,057	-319,139 Reduced 74.59%	108,709 $59,000
Q4 2021 Feb 08, 2022	BUY	$0.57 - $1.29 $221,794 - $501,955	389,113 Added 1004.55%	427,848 $249,000
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $4,582 - $7,017	4,128 Added 11.93%	38,735 $47,000
Q2 2021 Sep 13, 2021	BUY	$1.46 - $2.25 $50,526 - $77,865	34,607 New	34,607 $59,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.